June 2, 2022
Life Sciences
  • USC’s Schaeffer Center for Health Policy and Economics released a report examining how pharmacy benefit managers’ (PBMs) tactics such as spread pricing and copay clawbacks are driving up consumers’ costs for generic drugs. For example, Medicare Part D standalone drug plans paid $2.6 billion more for 184 generic drugs when compared the prices that Costco members paid in cash for the same medicines. The researchers suggested two requirements to counteract the trend: transparent reporting from PBMs and PBMs using fixed fees in their transactions. (Report here)